1. Home
  2. RCKT vs EVCM Comparison

RCKT vs EVCM Comparison

Compare RCKT & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • EVCM
  • Stock Information
  • Founded
  • RCKT 1999
  • EVCM 2006
  • Country
  • RCKT United States
  • EVCM United States
  • Employees
  • RCKT N/A
  • EVCM N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • EVCM EDP Services
  • Sector
  • RCKT Health Care
  • EVCM Technology
  • Exchange
  • RCKT Nasdaq
  • EVCM Nasdaq
  • Market Cap
  • RCKT 328.6M
  • EVCM 2.0B
  • IPO Year
  • RCKT N/A
  • EVCM 2021
  • Fundamental
  • Price
  • RCKT $3.71
  • EVCM $10.94
  • Analyst Decision
  • RCKT Buy
  • EVCM Hold
  • Analyst Count
  • RCKT 13
  • EVCM 9
  • Target Price
  • RCKT $12.88
  • EVCM $11.89
  • AVG Volume (30 Days)
  • RCKT 3.3M
  • EVCM 184.0K
  • Earning Date
  • RCKT 11-06-2025
  • EVCM 11-11-2025
  • Dividend Yield
  • RCKT N/A
  • EVCM N/A
  • EPS Growth
  • RCKT N/A
  • EVCM N/A
  • EPS
  • RCKT N/A
  • EVCM N/A
  • Revenue
  • RCKT N/A
  • EVCM $710,678,000.00
  • Revenue This Year
  • RCKT N/A
  • EVCM N/A
  • Revenue Next Year
  • RCKT $3,592.75
  • EVCM $5.95
  • P/E Ratio
  • RCKT N/A
  • EVCM N/A
  • Revenue Growth
  • RCKT N/A
  • EVCM 14.15
  • 52 Week Low
  • RCKT $2.19
  • EVCM $8.10
  • 52 Week High
  • RCKT $18.89
  • EVCM $12.34
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 55.72
  • EVCM 45.64
  • Support Level
  • RCKT $3.41
  • EVCM $10.47
  • Resistance Level
  • RCKT $4.51
  • EVCM $11.28
  • Average True Range (ATR)
  • RCKT 0.27
  • EVCM 0.35
  • MACD
  • RCKT 0.07
  • EVCM -0.02
  • Stochastic Oscillator
  • RCKT 43.99
  • EVCM 48.15

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About EVCM EverCommerce Inc.

EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.

Share on Social Networks: